Published in Circulation on June 27, 2000
Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol (2009) 1.78
Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol (2006) 1.72
LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm (2013) 1.35
HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol (2010) 1.32
Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A (2003) 1.29
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging (2010) 1.14
Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals. Diabetes Care (2009) 1.05
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci (2012) 1.04
Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int (2014) 1.03
LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem J (2006) 1.00
Flow-dependent cellular mechanotransduction in atherosclerosis. J Cell Sci (2013) 1.00
Innate immune activation in obesity. Mol Aspects Med (2012) 0.99
Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol (2009) 0.98
C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways. Int Rev Immunol (2013) 0.98
Infection and Atherosclerosis Development. Arch Med Res (2015) 0.96
Hsa-let-7g miRNA targets caspase-3 and inhibits the apoptosis induced by ox-LDL in endothelial cells. Int J Mol Sci (2013) 0.96
Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J (2001) 0.95
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications. Vasc Health Risk Manag (2007) 0.93
Radiolabelled probes for imaging of atherosclerotic plaques. Am J Nucl Med Mol Imaging (2012) 0.93
MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacol Res (2013) 0.92
Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand. J Biol Chem (2011) 0.92
Telomeres and atherosclerosis. Cardiovasc J Afr (2012) 0.89
Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med (2015) 0.89
Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations. Cardiovasc Res (2014) 0.87
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol (2013) 0.87
The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients. BMC Nephrol (2011) 0.86
Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells. Microbes Infect (2011) 0.86
LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Ther (2011) 0.85
Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells. Biochem J (2013) 0.85
Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox. Proc Jpn Acad Ser B Phys Biol Sci (2011) 0.85
Ox-LDL promotes migration and adhesion of bone marrow-derived mesenchymal stem cells via regulation of MCP-1 expression. Mediators Inflamm (2013) 0.85
LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J Lipid Res (2009) 0.85
Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1. Pathog Dis (2013) 0.84
Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1). Br J Pharmacol (2015) 0.83
Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathways. Cell Adh Migr (2015) 0.83
Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways. J Cardiovasc Thorac Res (2013) 0.82
Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. J Med Biochem (2015) 0.80
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol Dial Transplant (2010) 0.80
Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats. Crit Care (2010) 0.80
Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant. BMC Struct Biol (2007) 0.80
Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells. PLoS One (2015) 0.79
LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy. Mol Ther Nucleic Acids (2012) 0.79
Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested. Pathog Dis (2014) 0.78
Human cytomegalovirus-encoded miR-US25-1 aggravates the oxidised low density lipoprotein-induced apoptosis of endothelial cells. Biomed Res Int (2014) 0.78
Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis. J Clin Biochem Nutr (2012) 0.78
Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor. FEBS Lett (2014) 0.77
The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex. Glycoconj J (2012) 0.77
Synergistic effect of local endothelial shear stress and systemic hypercholesterolemia on coronary atherosclerotic plaque progression and composition in pigs. Int J Cardiol (2013) 0.76
Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function. Stem Cells Transl Med (2014) 0.76
LOX-1 plays an important role in ischemia-induced angiogenesis of limbs. PLoS One (2014) 0.76
Lipid Abnormalities and Inflammation in HIV Inflection. Curr HIV/AIDS Rep (2016) 0.75
Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice. J Vasc Res (2016) 0.75
Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1). Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.75
6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 Signaling. Evid Based Complement Alternat Med (2013) 0.75
Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin. PLoS One (2016) 0.75
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines. Oxid Med Cell Longev (2015) 0.75
Oxidative Stress and Inflammation Differentially Elevated in Objective Versus Habitual Subjective Reduced Sleep Duration in Obstructive Sleep Apnea. Sleep (2016) 0.75
Establishment of combined analytical method to extract the genes of interest from transcriptome data. Biochem Biophys Rep (2016) 0.75
Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep (2017) 0.75
Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Prevalence of coronary artery disease in Asian Indians. Am J Cardiol (1992) 2.90
Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res (1999) 1.76
Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol (1999) 1.74
Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation (1994) 1.63
Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res (2001) 1.61
Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol (1990) 1.58
Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol (2000) 1.57
Plasma serotonin levels and the platelet serotonin transporter. J Neurochem (2007) 1.49
Funding for biomedical research: What happened to our share of the nation's wealth? Chest (1998) 1.40
Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J (1996) 1.20
Evaluation of venous and arterial conduit patency by 16-slice spiral computed tomography. Circulation (2004) 1.19
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet (2003) 1.12
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation (2000) 1.12
Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol (1998) 1.10
Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins. Am J Physiol Heart Circ Physiol (2001) 1.09
Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. J Cardiovasc Pharmacol (1998) 1.07
Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J (1999) 1.05
Pleuropericarditis and pericardial tamponade associated with inflammatory bowel disease. J Ark Med Soc (2005) 1.04
Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol (1990) 1.04
A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease. Qual Saf Health Care (2005) 1.03
Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (1998) 1.02
Vitamins C and E prolong time to arterial thrombosis in rats. J Nutr (1999) 1.01
Exercise and myocardial tolerance to ischaemia-reperfusion. Acta Physiol Scand (2004) 0.95
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. Am J Physiol Heart Circ Physiol (2006) 0.95
Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun (2000) 0.94
Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol (1997) 0.94
Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol (1996) 0.94
Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation. Role of P-selectin. Arterioscler Thromb Vasc Biol (1995) 0.92
Inhibition of arterial thrombus formation by ApoA1 Milano. Arterioscler Thromb Vasc Biol (1999) 0.92
Systemic human Netrin-1 gene delivery by adeno-associated virus type 8 alters leukocyte accumulation and atherogenesis in vivo. Gene Ther (2010) 0.92
Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta(1). J Pharmacol Exp Ther (1999) 0.91
Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients. Am Heart J (1985) 0.90
Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J Mol Cell Cardiol (1988) 0.89
Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. Am J Physiol (1998) 0.89
Tumor necrosis factor-alpha enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C. Cardiovasc Res (1999) 0.89
Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital. Clin Cardiol (2002) 0.88
Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb Res (1994) 0.88
Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism. Circulation (1987) 0.87
Traditional risk factors and acute myocardial infarction in patients hospitalized with cocaine-associated chest pain. Clin Cardiol (2007) 0.87
Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator. J Am Coll Cardiol (1992) 0.87
Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J Pharmacol Exp Ther (1996) 0.87
Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release. J Pharmacol Exp Ther (1991) 0.86
Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J Lab Clin Med (1990) 0.86
Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury. Gene Ther (2007) 0.86
Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation (2000) 0.86
Anti-thrombotic effects of atorvastatin--an effect unrelated to lipid lowering. J Cardiovasc Pharmacol Ther (2002) 0.86
Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circ Res (2001) 0.86
Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts. Circulation (1997) 0.85
LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Ther (2011) 0.85
Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids (1991) 0.85
Co-purification of 130 kD nitric oxide synthase and a 22 kD link protein from human neutrophils. Biochem Biophys Res Commun (1992) 0.84
Inhibitory effect of high-density lipoprotein on platelet function is mediated by increase in nitric oxide synthase activity in platelets. Life Sci (1994) 0.83
Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxide. Br J Pharmacol (1997) 0.83
Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am J Physiol (1999) 0.83
TGF-beta(1) modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol (2001) 0.83
Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res (1994) 0.83
Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. Am J Physiol (1997) 0.83
[New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases]. Clin Ter (2007) 0.83
Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol (1996) 0.82
Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia (2005) 0.82
Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells. Hypertension (2001) 0.81
Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res (2000) 0.81
Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA. Circ Res (1998) 0.81
Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther (2002) 0.81
Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol. Arch Intern Med (1987) 0.81
Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus. Am J Cardiol (1990) 0.81
Angiotensin-converting enzyme inhibitor-induced pancreatitis. Clin Cardiol (1999) 0.81
Serum lidocaine concentrations following application to the oropharynx: effects of cimetidine. Ther Drug Monit (1987) 0.80
Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation. Cardiovasc Res (1999) 0.80
Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J (1995) 0.80
Platelet inhibitory effect of nitroglycerin in platelet-rich plasma: relevance of glutathione-s-transferases in plasma. J Investig Med (1996) 0.80
Plasma treatment of polyurethane coating for improving endothelial cell growth and adhesion. J Biomater Sci Polym Ed (2005) 0.80
Mathematical estimation of the potential effect of vascular remodelling/dilatation on B-mode ultrasound intima-medial thickness. QJM (2004) 0.80
Effects of exercise-induced oxidative stress on nitric oxide release and antioxidant activity. Am J Cardiol (1997) 0.80
Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J (1993) 0.79
Endothelium-dependent relaxation of rat aortic rings by leukotriene D4: importance of the magnitude of preload. Eicosanoids (1989) 0.79
Interactions between the renin-angiotensin system and dyslipidemia: relevance in atherogenesis and therapy of coronary heart disease. Indian Heart J (2001) 0.79
Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol (1991) 0.79
Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism. Am J Cardiol (1985) 0.79
Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors. Ther Adv Cardiovasc Dis (2012) 0.79
Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Am J Physiol (1988) 0.79
Biochemical and ultrastructural integrity of the saphenous vein conduit during coronary artery bypass grafting. Preliminary results of the effect of papaverine. J Thorac Cardiovasc Surg (1984) 0.79
Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J Lab Clin Med (1990) 0.79
5-Hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1. Am J Physiol (1992) 0.79
Nitric oxide synthase in adult red blood cells: vestige of an earlier age or a biologically active enzyme? J Lab Clin Med (2000) 0.78
Anticoagulation in coronary heart disease: heparin and warfarin trials. Cardiovasc Clin (1987) 0.78
Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension. Clin Pharmacol Ther (1984) 0.78
Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process? Clin Cardiol (2005) 0.78
Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits. Biochem Biophys Res Commun (2001) 0.78
HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells. J Viral Hepat (2006) 0.78
Modulation of cardiovascular remodeling with statins: fact or fiction? Curr Vasc Pharmacol (2005) 0.78
Leukotriene D4 potentiates the contractile effects of epinephrine and norepinephrine on rat aortic rings. J Pharmacol Exp Ther (1988) 0.78
Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis. Clin Cardiol (2000) 0.78
Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis. Cardiovasc Res (1995) 0.78
Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats. Am J Physiol (1998) 0.78
gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells. Biochem Biophys Res Commun (1999) 0.78
Effects of fish oil on some parameters of fibrinolysis and lipoprotein(a) in healthy subjects. Am J Cardiol (1994) 0.78
Nonplatelet-mediated effects of aspirin. Drugs Today (Barc) (2002) 0.78
Effect of stable fish oil on arterial thrombogenesis, platelet aggregation, and superoxide dismutase activity. J Cardiovasc Pharmacol (2000) 0.78
Myocardial angiotensin II receptor expression and ischemia-reperfusion injury. Vasc Med (1998) 0.78